Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for Chronic Granulomatous Disease (CGD)
Sites in Concord +49 more locations
Sponsor: Ensoma
Sex: All·Age: All ages
Code: NCT06605378·Recruiting·Listed Sep 2024
Paid Clinical Trials in Concord, NH
As of August 2026, 20 paid clinical trials are recruiting in Concord, New Hampshire. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Concord offers studies at sites including New Hampshire Oncology Hematology PA-Concord for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Concord
Trials by drug in Concord
Filter results
Filter results
20 clinical trials
Get a weekly email when new trials open in Concord, NH.
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
for Amblyopia
Sites in Concord +12 more locations
Sponsor: Luminopia
Sex: All·Age: All ages
Code: NCT06429280·Recruiting·Listed May 2024
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
for Lung Non-Small Cell Carcinoma
Sites in Concord, Manchester +623 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04267848·Phase 3·Recruiting·Listed Feb 2020
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
for Stage III Colon Cancer
Sites in Concord, Manchester +913 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
for Anatomic Stage II Breast Cancer AJCC v8
Sites in Concord, Manchester +777 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT05812807·Phase 3·Recruiting·Listed Apr 2023
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for Anatomic Stage I Breast Cancer AJCC v8
Sites in Concord, Manchester +591 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06876714·Phase 3·Recruiting·Listed Mar 2025
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
for Acute Lymphoblastic Leukemia
Sites in Concord, Manchester +616 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 40 - 75·Accepts healthy volunteers
Code: NCT05334069·Recruiting·Listed Apr 2022
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
for Previously Treated Non-Small Cell Lung Cancer
Sites in Concord, Manchester +948 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT03851445·Phase 2, Phase 3·Recruiting·Listed Feb 2019
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for Recurrent Lung Non-Small Cell Carcinoma
Sites in Concord, Manchester +370 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT05642572·Phase 2·Recruiting·Listed Dec 2022
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
for Lymphoma, Non-Hodgkin
Sites in Concord, Manchester +144 more locations
Sponsor: American Society of Clinical Oncology
Sex: All·Age: 12+
Code: NCT02693535·Phase 2·Recruiting·Listed Feb 2016
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for Breast Cancer
Sites in Concord, Manchester +44 more locations
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: 18+
Code: NCT04893109·Phase 2·Recruiting·Listed May 2021
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for Recurrent Lung Non-Small Cell Carcinoma
Drug: Cemiplimab
Sites in Concord, Manchester +379 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT06616584·Phase 2, Phase 3·Recruiting·Listed Sep 2024
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for Recurrent Lung Non-Small Cell Carcinoma
Sites in Concord, Manchester +239 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18 Minutes+
Code: NCT06031688·Phase 2·Recruiting·Listed Sep 2023
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
for Anatomic Stage IV Breast Cancer AJCC v8
Sites in Concord, Manchester +584 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT03723928·Recruiting·Listed Oct 2018
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for Lung Non-Small Cell Carcinoma
Sites in Concord, Manchester +241 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT06116682·Phase 2·Recruiting·Listed Nov 2023
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
for Anxiety Disorders
Sites in Concord, Manchester +4 more locations
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All·Age: 18 - 100
Code: NCT06898593·Recruiting·Listed Mar 2025
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
for Anatomic Stage I Breast Cancer AJCC v8
Sites in Concord, Manchester +913 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT05929768·Phase 3·Recruiting·Listed Jul 2023
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
for Advanced Cancer
Sites in Concord, Manchester +4 more locations
Sponsor: Alliance Foundation Trials, LLC.
Sex: All·Age: 21+
Code: NCT06963723·Recruiting·Listed May 2025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for Castration Levels of Testosterone
Sites in Concord, Manchester +292 more locations
Sponsor: SWOG Cancer Research Network
Sex: Male·Age: 18+
Code: NCT03678025·Phase 3·Recruiting·Listed Sep 2018
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
for Advanced Pancreatic Carcinoma
Sites in Concord +108 more locations
Sponsor: Sameek Roychowdhury
Sex: All·Age: 18+
Code: NCT06906562·Phase 2·Recruiting·Listed Apr 2025
Top Research Study Locations in Concord
Researchers run research studies in Concord, NH at 8 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| New Hampshire Oncology Hematology PA-Concord | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 13 |
| Concord Eye Center | Amblyopia | 1 |
| Dartmouth Hitchcock Concord Family Medicine | Anxiety Disorders, Depression Disorders | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| NH Oncology - Hematology, PA | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| NH Oncology-Hematology, PA - Payson Center for Cancer Care | Breast Cancer, HER2-positive Breast Cancer | 1 |
| New Hampshire Oncology-Hematology, PA | Advanced Cancer, Metastatic Cancer | 1 |
| Ohio State University-Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
Active & Upcoming Studies in Concord (2026)
Recruiting trials in Concord grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
- A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations · Phase 2 · Sameek Roychowdhury
Mental health & behavior (1 active study)
- Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients · Dartmouth-Hitchcock Medical Center
Common conditions studied in Concord
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Concord
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Alliance Foundation Trials, LLC.
- American Society of Clinical Oncology
- Dana-Farber Cancer Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Concord?
There are approximately 20 recruiting clinical trials in Concord, New Hampshire listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Concord pay participants?
Most recruiting trials in Concord compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Concord?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Concord?
The most common conditions under active study in Concord include Anatomic Stage II Breast Cancer AJCC v8 (3), Recurrent Lung Non-Small Cell Carcinoma (3), Stage IV Lung Cancer AJCC v8 (3), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Concord?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Concord on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Concord?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Concord?
Recruiting research sites in Concord include New Hampshire Oncology Hematology PA-Concord, Concord Eye Center, Dartmouth Hitchcock Concord Family Medicine, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Concord right now?
The largest active categories in Concord are Cancer & tumors (17), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.